[Treatment of laryngeal dystonia with botulinum toxin].

Authors:
Arno Olthoff
Arno Olthoff
University of Göttingen
Maria Grosheva
Maria Grosheva
University of Cologne
Köln | Germany
Gerhard Reichel
Gerhard Reichel
The Parkinson's and Movement Disorder Institute
United States
Gerd Fabian Volk
Gerd Fabian Volk
Jena University Hospital
Germany
Rainer Laskawi
Rainer Laskawi
University of Göttingen

Fortschr Neurol Psychiatr 2017 Aug 25;85(8):450-462. Epub 2017 Aug 25.

Klinik für Hals-, Nasen- und Ohrenheilkunde, Universitätsmedizin Göttingen.

The treatment of laryngeal dystonias with botulinum toxin is successful. Every patient suffering from a laryngeal dystonia should be assured of high quality therapeutic intervention. Therefore it is important to establish general standards by experts in this field. In this connection, we want to focus here on different relevant aspects of laryngeal dystonias. This includes new aspects in etiology, anatomical landmarks for the injection, standards in diagnostics and therapy and finally open issues needing discussion.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-115644DOI Listing
August 2017
4 Reads

Publication Analysis

Top Keywords

laryngeal dystonia
8
laryngeal dystonias
8
focus relevant
4
connection focus
4
relevant aspects
4
aspects laryngeal
4
dystonias includes
4
field connection
4
experts field
4
therapeutic intervention
4
quality therapeutic
4
intervention establish
4
establish general
4
standards experts
4
includes aspects
4
aspects etiology
4
therapy finally
4
diagnostics therapy
4
finally open
4
open issues
4

Similar Publications

[Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].

Arq Neuropsiquiatr 2001 Mar;59(1):97-100

Departamento de Clínica Médica, Hospital de Clínicas, Universidade Federal do Paraná, Brazil.

Laryngeal dystonia (spasmodic dysphonia) is a movement disorder characterized by involuntary contractions of laryngeal muscles involved with vocalization. The introduction of botulinum toxin in the treatment of laryngeal dystonia had a major clinical impact due to the striking improvement of symptoms. We report the preliminary results of therapeutical use of botulinum toxin in the treatment of twelve patients with laryngeal dystonia. Read More

View Article
March 2001

[Laryngeal dystonia].

Authors:
E R Barbosa

Arq Neuropsiquiatr 2001 Sep;59(3-B):829

View Article
September 2001

Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: comparing different botulinum toxin preparations.

Eur J Neurol 2006 Feb;13 Suppl 1:36-41

The Parkinson's and Movement Disorder Institute, Fountain Valley, CA 92708, USA.

Spasmodic dysphonia (SD) is a focal dystonia characterized by a strained, strangled voice. Botulinum toxin is a symptomatic treatment for SD and has become the mainstay of therapy over the last two decades. In this manuscript, we briefly review different laryngeal muscle hyperactivity syndromes, their injection techniques and toxins currently available. Read More

View Article
February 2006

Sleep-related adductor laryngeal dystonia causing sleep apnea: a sleep-related breathing disorder diagnosed with sleep endoscopy and treated with botulinum toxin.

Laryngoscope 2013 Jun 10;123(6):1560-3. Epub 2013 May 10.

Department of Neurosciences, Institute of Otolaryngology, Padova University, Padova, Italy.

Objectives/hypothesis: Obstructive sleep apnea syndrome (OSAS) is a chronic condition, characterized by recurrent episodes of upper airway collapse during sleep, which affects up to 5% of adults in the Western population. The muscle tone of the human body ordinarily relaxes during sleep, thus causing airway obstruction and leading to sleep apnea. We report a case of a 68-years old male in which dystonic closure of the larynx during sleep caused OSAS. Read More

View Article
June 2013